Emcure Pharmaceuticals Approves Subsidiary Amalgamation Scheme
Emcure Pharmaceuticals’ board approves a draft scheme to amalgamate its wholly owned subsidiaries Zuventus Healthcare and Emcutix Biopharmaceuticals with the parent company.
Emcutix Biopharmaceuticals | 14/10/2026 | By News Bureau
Emcure Launches New Entity Emcutix Biopharmaceuticals for Dermatology Sector
As a part of this strategic initiative, Emcure's existing dermatology business will also operate under Emcutix.
Emcutix Biopharmaceuticals | 29/10/2024 | By Aishwarya | 1157
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy